Beacon Pointe Advisors LLC Decreases Holdings in iShares Biotechnology ETF $IBB

Beacon Pointe Advisors LLC decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 17.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,341 shares of the financial services provider’s stock after selling 8,734 shares during the period. Beacon Pointe Advisors LLC owned 0.10% of iShares Biotechnology ETF worth $5,230,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Employees Retirement System of Texas purchased a new stake in shares of iShares Biotechnology ETF in the second quarter worth approximately $25,049,000. Bronte Capital Management Pty Ltd. grew its position in iShares Biotechnology ETF by 12.6% in the 2nd quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock valued at $37,000 after acquiring an additional 32,947 shares during the last quarter. Atlantic Union Bankshares Corp purchased a new stake in iShares Biotechnology ETF in the second quarter worth $2,219,000. KFG Wealth Management LLC lifted its position in shares of iShares Biotechnology ETF by 4.8% during the second quarter. KFG Wealth Management LLC now owns 2,444 shares of the financial services provider’s stock worth $309,000 after purchasing an additional 112 shares during the last quarter. Finally, Telos Capital Management Inc. boosted its stake in shares of iShares Biotechnology ETF by 4.0% during the second quarter. Telos Capital Management Inc. now owns 11,336 shares of the financial services provider’s stock valued at $1,434,000 after purchasing an additional 436 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 1.8%

IBB stock opened at $172.23 on Thursday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $174.40. The firm’s 50-day moving average is $158.12 and its 200 day moving average is $141.42.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were given a dividend of $0.0828 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.